Clinical Trial Update: Real World Study of PEG-rhG-CSF in Prevention of Chemotherapy-induced Neutropenia

View source ↗

Summary

A real-world study evaluating PEG-rhG-CSF for the prevention of chemotherapy-induced neutropenia and associated myelosuppression.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Neutropenia
• Myelosuppression

Drugs mentioned

• PEG-rhG-CSF (pegylated recombinant human granulocyte colony-stimulating factor)

Snippet

Sponsor: CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. | Conditions: Chemotherapy-induced Neutropenia, Myelosuppression | Status: UNKNOWN